Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA
Advancing DNA vaccines & Immunotherapies for HIV, Cancers & Infectious Diseases HONG KONG SAR – Media OutReach – 27 July 2023 – Immuno Cure BioTech (“Immuno Cure“) is pleased to announce today that it has closed the US$12 million tranche in the US$27 million Series A fundraising round. Led by the AEF Greater Bay Area Fund that Gobi Partners GBA (“Gobi GBA“) manages, this round will be […]
